Media Tip Sheet: FDA Cracks Down on Counterfeit Botox


November 6, 2025

The FDA has issued warning letters to 18 websites illegally selling counterfeit or unapproved versions of Botox and similar injectable drugs.

These products have been tied to reports of injuries and potentially toxic side effects, posing real threats to consumers seeking affordable cosmetic treatments online.

Here’s what’s important:

  • The FDA has received reports of injuries linked to these unapproved products, including toxic reactions resembling botulism.
  • Counterfeit Botox may be mislabeled, improperly stored, or contaminated, increasing the risk of nerve damage and life-threatening complications.
  • While Botox has valid medical and aesthetic uses when administered by licensed professionals, patients should be wary of discounted or online offers outside clinical settings.

The George Washington University has experts available to discuss the counterfeit versions of Botox, what consumers should look for and the symptoms. If you would like to schedule an interview, please contact Katelyn Deckelbaum, katelyn [dot] deckelbaumatgwu [dot] edu (katelyn[dot]deckelbaum[at]gwu[dot]edu).

Adam Friedman, is a professor and the chair of dermatology at GW School of Medicine and Health Sciences.

Pooja Sodha, is the director for the center for laser and cosmetic dermatology at GW School of Medicine and Health Sciences. 
 

-GW-